Amryt Pharma Share Discussion Threads

[papillon] 25/1/2017 18:00

Below average volume today.

[icebreaker] 25/1/2017 13:01

Sure understood, but 'next month' or 'in March' would indicate that they have a commencement date fixed.

If it's not fixed, it's probably not happening this qtr!

[digadee] 25/1/2017 12:47

Icebreaker, we are now in Q1 so the wording has to change ie "coming months". Stating it as Q1 in Q1 would raise that very question ie we are in Q1.

[icebreaker] 25/1/2017 11:00

Episalvan P3 'in the coming months' so doesn't sound like 1st quarter as previously advised!

[bigwavedave] 25/1/2017 10:45

youtube pitch

[papillon] 24/1/2017 11:06

The AMYT will continue to drift until we get the next news. That's the way of most AIM listed shares. Pointless posting until we see the next RNS. I'll continue to hold and may add if the share price drops back towards 16p.

[icebreaker] 20/1/2017 13:17

I would hope that the operational costs will be covered in part (eventually in full) by our recent alliance.

They are also accountable to the EIB following their new €20M credit line so won't be able line their pockets at our expense.

[jacksonpollack] 20/1/2017 12:40

Nearly a year in operation and all it does is go down. The directors gravy train keeps chugging along. Admin costs are horrendous here given the contempt the directors hold shareholders in.

[papillon] 19/1/2017 13:04

I'm NOT worried about the lack of investor interest, pottermagic, just commenting on it, that's all. Where in my post does it say that I'm worried?

[icebreaker] 19/1/2017 12:03

The prospects are definately good. By now they should be asking questions of their PR firm. The message is clearly not getting to those that need to know!

We should not be merely waiting for someone to take notice!

[pottermagic2310] 19/1/2017 09:16

Why worry about Investor interest at such a low level.
It's a Business that simply needs to generate Products and/or make good, reported progress with its development of Products.
The Market valuation will thrive on actual progress with Products.
A bigger Fish may show considerable interest, to the benefit of the Market valuation, based on good progress.
All we can do is sit & wait

[papillon] 18/1/2017 23:36

Another day of very low volume. Currently investors are not interested in AMYT. We await the next news; only that will rekindle investor interest.

[papillon] 16/1/2017 13:31

Looking more and more likely that the chart watchers are going to be proved correct and that the GAP UP between 16.5 - 18p that occurred on the candlestick chart following the good news issued in early December will need to be FILLED before further upwards progress can seen in the share price We shall see!

[icebreaker] 13/1/2017 18:56

Understood Pottermagic - so the market may not be established, product less saleable, fewer instances of the ailment (not sure about that last one), but if we sell half as much despite having twice (or maybe 3 times) the number of people....

That will do me!

[pottermagic2310] 13/1/2017 18:23

I expect it's about Demand and affordability... we've been given Markets that the Product is perhaps less attractive to, maybe less affordable, possibly fewer instances of the ailment itself occurring ?
Novelion wasn't going to give us it's Primary Market where it already makes plenty of Sales and a sizeable Profit... it's given us a very secondary target Market where it hasn't made much traction itself.

[icebreaker] 13/1/2017 16:21

According to Novelion's 'preliminary total net product sales for 2016', the company anticipates $100 Million from Juxtapid (lomitapide). We have been licenced exclusively to sell the hard capsule version (Lojuxta) in the EEA, Middle East and North Africa. 70% of Novelion's sales appear to be in the US.



Assuming that the territories we now control have over twice the population of the US, why are we languishing at £38M market cap. What am I missing here?

[papillon] 12/1/2017 15:48

Looking like the chart followers could be proved correct on this one and that the GAP UP on the candlestick chart between 16.5 - 18p that happened early in December will be filled. We shall see. What will be will be. If the share price does fall back below 17p it could be a good time to top up.

[papillon] 11/1/2017 19:49

Many thanks, Buffy.

[buffythebuffoon] 11/1/2017 10:31

Pap,

Just one of several explanations.

hxxps://www.morganmckinley.ie/article/difference-between-pharmaceutical-and-biotechnology

Agreed a bit confusing.

Some may say that all biopharmas are biotechs, but not all biotechs are biopharmas.

I won't care when the company finally hits it big.

Buffy

[papillon] 10/1/2017 18:59

Here's my post from around a month ago.

papillon 15 Dec '16 - 12:23 - 714 of 774 1 0 Edit
Looks like the AMYT share price could have run out of steam in the short term. There is an intraday "GAP" on the AMYT candlestick chart from earlier this month following the release of good news. That "GAP" is between 16.5p and 18p. Chartists (of which I'm not one though I don't completely ignore them like some) would argue that that "GAP" needs to be filled. If those chartists are correct then the AMYT share price will drop back to 16.5p intraday before further upward progress can take place. We shall see. I can't predict the future and I'm not interested in short term share price fluctuations since rightly, or wrongly, I believe that holding AMYT for the longer term will make me an exceedingly good profit. My AMYT shares will stay in my bottom drawer. I await the next news with anticipation.

[papillon] 10/1/2017 18:55

GAP UP between 16.5 - 18.0 pence that occurred in early December about to be CLOSED? Looking possible! Gap ups are often "closed" by a drop back in the share price before the climb back up restarts. We shall see!

PS. I first mentioned that this Gap up might need to be closed a month, or so, ago, but it doesn't always happen. Is it happening now because traders are closing positions?

[icebreaker] 10/1/2017 16:52

I knew as I was writing it that it was a daft comment ....

[bigwavedave] 10/1/2017 16:31

Oh well. Just when you thought... :-/

[icebreaker] 10/1/2017 15:30

Lots of sells but at least the price is holding (so far). Let's hope once these sells are finished we can start to climb!